At what enterprise value was ALLIANCE MEDICAL acquired in 2016?

During the acquisition of ALLIANCE MEDICAL by LIFE HEALTHCARE in 2016, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b GBP. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.4x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of ALLIANCE MEDICAL when it was acquired by LIFE HEALTHCARE?

The estimated EV/EBITDA multiple for ALLIANCE MEDICAL is in the range of 10x - 18x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.4x. Join our community for free to access full valuation data and industry trends.

When was ALLIANCE MEDICAL acquired by LIFE HEALTHCARE?

ALLIANCE MEDICAL was acquired by LIFE HEALTHCARE in 2016.

What was the revenue of ALLIANCE MEDICAL at the time of the deal?

The revenue of ALLIANCE MEDICAL at the time of the deal is estimated to be in the range of 150M - 250M GBP. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of ALLIANCE MEDICAL during the acquisition?

ALLIANCE MEDICAL's EBITDA is estimated to be in the range of 50M - 100M GBP. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the ALLIANCE MEDICAL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the ALLIANCE MEDICAL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.lifehealthcare.co.za/media/1231/investor-presentation-16-november-2016.pdf

← DATABASE

Home Database Healthcare & PharmaALLIANCE MEDICAL

11/2016

ALLIANCE MEDICAL acquired by LIFE HEALTHCARE

UNITED KINGDOM Providers & Facilities / Outpatient Care / Radiology EV 500M - 1.5b GBP

Context

Triton Partners has agreed to sell the radiology division of Aleris to EQT Infrastructure in a strategic carve-out transaction. This partial exit allows Triton to streamline Aleris into a focused specialist healthcare provider, while simultaneously divesting its primary care operations to another buyer. For EQT Infrastructure, the acquisition is a major step in building a pan-European leader in diagnostic imaging. By combining Aleris Imaging's dominant Nordic footprint with its existing German operations (Meine Radiologie/Blikk), EQT creates a scaled platform capable of investing heavily in digitalization and advanced medical equipment. The deal reflects the growing trend of treating healthcare diagnostics as "essential social infrastructure" due to their critical role in patient pathways and high barriers to entry.

ALLIANCE MEDICAL, which reported an EBITDA margin of LOGIN in 2016, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Alliance Medical is Europe’s leading independent provider of medical imaging services, specializing in outsourced diagnostic solutions for both public and private healthcare systems. Headquartered in the UK, the company operates an extensive pan-European network of over 200 sites across countries including the UK, Italy, Germany, Ireland, and Spain. Its business model is built on long-term, mission-critical partnerships (notably as a Tier 1 partner to the NHS) where it provides MRI, CT, PET-CT, and molecular imaging services through fixed centers and a fleet of high-tech mobile units. The organization integrates the entire imaging value chain, from infrastructure development to clinical service delivery and radiopharmaceutical production.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (GBP)

Year

Rev

EBITDA

EBIT

2016

2015

Other operations with ALLIANCE MEDICAL

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
10/2023	ICON INFRASTRUCTURE	ALLIANCE MEDICAL	UNITED KINGDOM	Providers & Facilities	Life Healthcare has agreed to sell 100% of Alliance Medical Group to iCON Infrastructure in a major cross-border carve-out. The transaction allows Life Healthcare, a South African hospital operator, to monetize its European assets and return capital to shareholders, while retaining its separate R&D division (Life Molecular Imaging). For iCON, the acquisition represents a strategic entry into the healthcare infrastructure space. The investment thesis treats diagnostic imaging networks as "critical infrastructure" essential for national health systems, offering stable cash flows and resilience against economic cycles. iCON plans to support the management team in expanding the network of scanning centers and radiopharmacy facilities.

REFERENCES

Valuation range: EV 500M - 1.5b GBP

Revenue range: 150M - 250M GBP

EBITDA range: 50M - 100M GBP

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ALLIANCE MEDICAL by LIFE HEALTHCARE are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: alliance medical

Acquirer: life healthcare